GSK obtains Japanese approval for Encruse Ellipta to treat COPD
GlaxoSmithKline (GSK) has obtained Japanese approval for its Encruse Ellipta (umeclidinium). The Japanese Ministry of Health, Labour and Welfare (MHLW) granted approval for...
Multisorb to Attend Interphex 2015
Multisorb Technologies has announced it will be exhibiting at Interphex in New York.
The event will take place from 20-22 April 2015 at the Javits...
Signum out-licenses SIG990 to Dermata to develop new topical treatment for rosacea
US-based biotechnology firm Signum Dermalogix has out-licensed SIG990, a new anti-inflammatory compound, to Dermata Therapeutics for the development of a topical product to treat...
Cipher Pharma buys Canadian rights to novel treatment for psoriasis and RA from Can-Fite Biopharma
Cipher Pharmaceuticals Inc., a rapidly growing specialty pharmaceutical dermatology company, has licensed the Canadian distribution rights to CF101, a novel chemical entity being developed...
Merck KGaA to tap Oschmann as new CEO
Merck KGaA is the latest company to join Big Pharma's recent round of executive musical chairs. The German drugmaker is promoting deputy chief executive...
Bangalore – The Silicon City, is now the Pharma City
"There is no second thought on the capability of the Indian pharma industry and Bangalore is gearing up to play its role as a...
CDSCO Ahmedabad becomes first ISO certified zonal regulatory office in India
In a strategic development, the zonal office of Central Drugs Standard Control Organisation (CDSCO) Ahmedabad was recognised with the certification of ISO 9001:2008 standards...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...